| Product NDC: | 42549-597 |
| Proprietary Name: | tizanidine hydrochloride |
| Non Proprietary Name: | tizanidine hydrochloride |
| Active Ingredient(s): | 4 mg/1 & nbsp; tizanidine hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42549-597 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076280 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020627 |
| Package NDC: | 42549-597-60 |
| Package Description: | 60 TABLET in 1 BOTTLE (42549-597-60) |
| NDC Code | 42549-597-60 |
| Proprietary Name | tizanidine hydrochloride |
| Package Description | 60 TABLET in 1 BOTTLE (42549-597-60) |
| Product NDC | 42549-597 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tizanidine hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020627 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | TIZANIDINE HYDROCHLORIDE |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |